About Us
About Guard Therapeutics
Vision, Business Model & Goal
The Board
Management
Research
Kidney disease
Science
Pipeline
RMC-035
GTX Peptides
Investor Relations
Financial calender
Financial reports
Share information
Corporate governance
General meetings
Newsroom
Press releases
Event calender
Analyses and presentations
Subscribe
Contact
Swe
Search
Presentation
19 Sep 2023
/
Investor webcast: CEO Tobias Agervald and CMO Michael Reusch presents AKITA Top-line results
Link to presentation:
https://financialhearings.com/event/47345